Compare KPTI & NCSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KPTI | NCSM |
|---|---|---|
| Founded | 2008 | 2006 |
| Country | United States | United States |
| Employees | 228 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oilfield Services/Equipment |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.8M | 170.3M |
| IPO Year | 2013 | 2017 |
| Metric | KPTI | NCSM |
|---|---|---|
| Price | $8.63 | $41.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | ★ 403.3K | 38.3K |
| Earning Date | 05-04-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 239.22 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $146,067,000.00 | $142,471,000.00 |
| Revenue This Year | N/A | $5.57 |
| Revenue Next Year | $22.36 | $4.81 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 0.57 | N/A |
| 52 Week Low | $3.65 | $28.65 |
| 52 Week High | $10.99 | $87.36 |
| Indicator | KPTI | NCSM |
|---|---|---|
| Relative Strength Index (RSI) | 52.53 | 29.75 |
| Support Level | $8.11 | $35.23 |
| Resistance Level | $9.00 | $43.62 |
| Average True Range (ATR) | 0.58 | 6.06 |
| MACD | -0.03 | -4.31 |
| Stochastic Oscillator | 33.12 | 5.70 |
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).
NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completion, and field development strategies. The company provides its products and services to E&P companies for use in onshore and offshore wells, predominantly those drilled with horizontal laterals in unconventional and conventional oil and natural gas formations. It also provides tracer diagnostics services and sells products for well construction including casing buoyancy systems, liner hanger systems and toe initiation sleeves, along with certain complementary products from third parties. The company operates in the United States, Canada and other countries, with the majority of its revenue generated from Canada.